# Naltrexone & SSRI in Alcoholics With Depression/PTSD

> **NCT00338962** · PHASE3 · COMPLETED · sponsor: **Yale University** · enrollment: 88 (actual)

## Conditions studied

- Alcoholism
- Depression
- PTSD

## Interventions

- **DRUG:** paroxetine
- **DRUG:** desipramine
- **DRUG:** Naltrexone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00338962
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2016-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00338962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00338962, "Naltrexone & SSRI in Alcoholics With Depression/PTSD". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00338962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*